IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis

Resonance Magnetic Imaging at the Acute Phase of Endocarditis: Diagnostic and Therapeutic Impact

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00144885

Acronym

IMAGE

Enrollment

150

Registered

2005-09-05

Start date

2005-06-30

Completion date

2008-12-31

Last updated

2009-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocarditis, Bacterial

Keywords

Endocarditis, RMI, Impact measure

Brief summary

Patients with definite or possible infective endocarditis are included in this protocol, at the acute phase of the disease.

Detailed description

Patients with definite or possible infective endocarditis are included in this protocol, at the acute phase of the disease. Resonance magnetic imaging (head and abdomen) will be performed systematically before Day 7. The impact on the diagnosis and therapeutic options will be assessed, as compared to pre resonance magnetic nuclear (RMN) imaging declaration.

Interventions

BEHAVIORALModification of therapy

Modification of the surgery date if adapted, modification of the antibiotics if adapted, based on RMI results

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Acute phase of infective endocarditis

Exclusion criteria

* Contra indication to RMN

Design outcomes

Primary

Measure	Time frame
Modification of therapeutic project	As soon as RMI is performed

Secondary

Measure	Time frame
Modification of diagnostic classification (Duke modified criteria)	As soon as RMI is performed

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026